Tempus AI

TEM · NASDAQ

$66.75+$2.41 (+3.75%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $64.34

Latest news

Press releaseOct 19, 8:30 AM ETBusiness Wire
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
Press releaseOct 15, 4:01 PM ETBusiness Wire
Tempus to Report Third Quarter 2026 Financial Results on November 2
Press releaseOct 15, 8:45 AM ETGlobe Newswire
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
Press releaseOct 13, 6:00 AM ETBusiness Wire
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
NewsOct 12, 9:00 AM ETNamrata Sen
Palantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns Both AI Extremes Reflect ‘Social Delusion’
NewsOct 7, 1:44 PM ETVandana Singh
Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure
Press releaseOct 7, 8:30 AM ETBusiness Wire
Tempus Announces Multi-Year Collaboration with Moderna and Merck
NewsOct 6, 1:11 PM ETPiero Cingari
S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today
NewsOct 6, 4:08 AM ETRishabh Mishra
Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’
NewsOct 1, 12:29 PM ETPiero Cingari
Stock Market Today: S&P 500 Slips as Micron Fails to Impress, 10-Year Yields Ease to 5.25%
Press releaseOct 1, 12:11 PM ETPRNewswire
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
Press releaseOct 1, 8:34 AM ETBusiness Wire
Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026
Press releaseSep 28, 8:00 AM ETBusiness Wire
Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation
NewsSep 23, 1:35 PM ET
10 Health Care Stocks Whale Activity In Today’s Session
Press releaseSep 21, 9:14 AM ETBusiness Wire
Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model
NewsSep 18, 12:08 PM ETAkanksha Bakshi
Why Is Tempus AI Stock Falling Friday?
NewsSep 17, 1:22 PM ETPiero Cingari
Nasdaq 100 Rallies as Oil Slides, Yields Retreat: Stock Market Today
NewsSep 16, 10:44 AM ETVandana Singh
Novo Nordisk, Anthropic Team Up For AI Drug Research
NewsSep 15, 1:27 PM ETPiero Cingari
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
NewsSep 14, 4:32 PM ET
'Tempus AI Founder Supports Anthropic CEO’s Call for Slowdown' - Bloomberg News
Press releaseSep 14, 10:00 AM ETPRNewswire
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
NewsSep 11, 8:45 AM ETAvi Kapoor
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’
Press releaseSep 11, 8:30 AM ETBusiness Wire
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
Press releaseSep 9, 4:01 PM ETBusiness Wire
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology
Press releaseSep 4, 8:30 AM ETBusiness Wire
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Press releaseSep 3, 8:55 AM ETPRNewswire
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
NewsSep 2, 2:10 PM ETLekha Gupta
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says
NewsSep 1, 12:25 PM ETChandrima Sanyal
Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
NewsAug 25, 10:25 PM ETShivdeep Dhaliwal
Cathie Wood Loads Up on Cerebras Systems Stock as AI Chip Race With Nvidia Heats Up — Ark Keeps on Dumping AMD Shares
NewsAug 24, 2:02 PM ETVandana Singh
What’s Going On With Tempus AI Stock on Monday?
NewsAug 24, 1:16 PM ETPiero Cingari
Memory Stocks Slide as Trump Threatens 50% Tariffs on Canadian Autos, Steel in 2027: Stock Market Today
Press releaseAug 24, 8:30 AM ETBusiness Wire
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
NewsAug 21, 10:47 AM ETHenry Khederian
Tempus AI Stock Climbs Friday: What's Driving the Move?
NewsAug 20, 1:02 PM ETPiero Cingari
Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today
NewsAug 19, 1:10 PM ETPiero Cingari
Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today
Press releaseJul 20, 8:30 AM ETBusiness Wire
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
NewsMay 7, 11:08 PM ETShivdeep Dhaliwal
Cathie Wood Dumps Another $3 Million In AMD Stock As Ark Invest Trims For Third Day Running, This Is the AI Stock She Is Buying Instead
Press releaseFeb 24, 4:01 PM ETBusiness Wire
Tempus Reports Fourth Quarter and Full Year 2025 Results
Press releaseNov 4, 4:01 PM ETBusiness Wire
Tempus Reports Third Quarter 2025 Results
Press releaseAug 8, 6:00 AM ETBusiness Wire
Tempus Reports Second Quarter 2025 Results
Press releaseMay 6, 4:01 PM ETBusiness Wire
Tempus Reports First Quarter 2025 Results
NewsMar 4, 3:36 PM ETChris Katje
EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank?
Press releaseFeb 24, 4:01 PM ETBusiness Wire
Tempus Reports Fourth Quarter and Full Year 2024 Results
Press releaseNov 4, 4:01 PM ETBusiness Wire
Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
Press releaseAug 6, 4:01 PM ETBusiness Wire
Tempus Reports Second Quarter 2024 Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus to Report Third Quarter 2026 Financial Results on November 2

The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape

Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases

Palantir CTO Says Some AI Researchers Are So Sure It Will Cure Cancer They’ve Started 'Smoking' — Warns Both AI Extremes Reflect ‘Social Delusion’

Tempus AI Doubles Down On Moderna and Merck Cancer Vaccine Infrastructure

Tempus Announces Multi-Year Collaboration with Moderna and Merck

S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today

Cathie Wood Claps Back After Being Confronted as ARKK Fell Nearly 15% While QQQ Soared 112% in Five Years — Calls It an ‘Incorrect Comparison’

Stock Market Today: S&P 500 Slips as Micron Fails to Impress, 10-Year Yields Ease to 5.25%

AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment

Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026

Tempus Receives FDA Clearance for its ECG-MR AI Product Designed to Identify Undiagnosed Mitral Regurgitation

10 Health Care Stocks Whale Activity In Today’s Session

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model

Why Is Tempus AI Stock Falling Friday?

Nasdaq 100 Rallies as Oil Slides, Yields Retreat: Stock Market Today

Novo Nordisk, Anthropic Team Up For AI Drug Research

10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today

'Tempus AI Founder Supports Anthropic CEO’s Call for Slowdown' - Bloomberg News

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033

Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’

Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation

Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology

Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Cathie Wood Loads Up on Cerebras Systems Stock as AI Chip Race With Nvidia Heats Up — Ark Keeps on Dumping AMD Shares

What’s Going On With Tempus AI Stock on Monday?

Memory Stocks Slide as Trump Threatens 50% Tariffs on Canadian Autos, Steel in 2027: Stock Market Today

Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs

Tempus AI Stock Climbs Friday: What's Driving the Move?

Bessent's Bond Rescue Fizzles, Walmart Craters 9%: Stock Market Today

Moderna Doubles, Gold Rallies To $4,500 As Dollar Sinks: Stock Market Today

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

Cathie Wood Dumps Another $3 Million In AMD Stock As Ark Invest Trims For Third Day Running, This Is the AI Stock She Is Buying Instead

Tempus Reports Fourth Quarter and Full Year 2025 Results

Tempus Reports Third Quarter 2025 Results

Tempus Reports Second Quarter 2025 Results

Tempus Reports First Quarter 2025 Results

EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank?

Tempus Reports Fourth Quarter and Full Year 2024 Results

Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics

Tempus Reports Second Quarter 2024 Results